Strategic Acquisition CrossRoads was acquired by Cabotprop for 45M in March 2024, indicating a potential alignment with larger medical device portfolios and distribution channels. Opportunities may exist to engage Cabot Properties or Cabot-prop-backed entities for joint go-to-market initiatives or to leverage their network for expanded hospital partnerships.

Targeted Markets Specialization in foot and ankle with a unique Staple Compression Plate technology and sterile-packed implants presents a compelling value proposition for orthopedic departments seeking faster healing and simplified OR workflows. Prioritize outreach to trauma and reconstructive teams focusing on fusion procedures and bunion repair.

Sustainable Advantage EcoSMART reusable instruments and gamma-sterilized service reduce waste and tray inefficiencies, aligning with sustainability goals of healthcare systems. Position EcoSMART as a cost-saving and environmentally responsible alternative to disposable instrument sets in procurement conversations.

Growth Partners Past funding from Runway Growth Capital and HealthpointCapital signals investor confidence and growth potential. Use this to explore co-investment or channel partnerships with growth-stage funds or distributors that value scalable, technology-driven orthopedic solutions.

Innovation Pipeline A history of MIS launches such as miniBunion and DynaBunion Lapidus systems shows an ongoing product development trajectory. Leverage this momentum to propose device refresh cycles, training programs, and bundled service agreements to banks of surgeons adopting new techniques.